Bluelinea SA (PA:ALBLU) — Market Cap & Net Worth
Market Cap & Net Worth: Bluelinea SA (ALBLU)
Bluelinea SA (PA:ALBLU) has a market capitalization of $3.00 Million (€2.57 Million) as of September 24, 2026. Listed on the PA stock exchange, this France-based company holds position #29569 globally and #539 in its home market, demonstrating a -6.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bluelinea SA's stock price €0.14 by its total outstanding shares 18327137 (18.33 Million). Also see balance sheet size of Bluelinea SA for a full breakdown of the balance sheet.
Bluelinea SA Market Cap History: 2015 to 2026
Bluelinea SA's market capitalization history from 2015 to 2026. Data shows change from $112.37 Million to $3.00 Million (-28.25% CAGR). Also see ALBLU cash generation efficiency for how efficiently the company converts equity into cash flow.
Bluelinea SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bluelinea SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check ALBLU stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
2.27x
Bluelinea SA's market cap is 2.27 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $112.37 Million | $7.22K | -$1.15K | 15563.33x | N/A |
| 2016 | $106.94 Million | $6.50K | -$3.31K | 16440.61x | N/A |
| 2017 | $108.60 Million | $6.61K | -$2.99K | 16425.94x | N/A |
| 2018 | $69.38 Million | $6.16 Million | -$2.74 Million | 11.26x | N/A |
| 2019 | $75.41 Million | $6.31 Million | -$2.79 Million | 11.96x | N/A |
| 2020 | $76.62 Million | $6.83 Million | -$2.70 Million | 11.23x | N/A |
| 2021 | $44.34 Million | $7.52 Million | -$3.30 Million | 5.89x | N/A |
| 2022 | $31.71 Million | $10.41 Million | -$1.54 Million | 3.05x | N/A |
| 2023 | $27.85 Million | $9.88 Million | -$1.62 Million | 2.82x | N/A |
| 2024 | $21.43 Million | $9.45 Million | -$1.27 Million | 2.27x | N/A |
Competitor Companies of ALBLU by Market Capitalization
Companies near Bluelinea SA in the global market cap rankings as of September 24, 2026. Review Bluelinea SA tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Bluelinea SA by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #122 globally with a market cap of $180.30 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #237 globally with a market cap of $105.52 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #122 | Abbott Laboratories | NYSE:ABT | $180.30 Billion | $103.69 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $90.77 |
| #237 | Stryker Corporation | NYSE:SYK | $105.52 Billion | $275.09 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Bluelinea SA Historical Marketcap From 2015 to 2026
Between 2015 and today, Bluelinea SA's market cap moved from $112.37 Million to $ 3.00 Million, with a yearly change of -28.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €3.00 Million | -71.43% |
| 2025 | €10.50 Million | -51.00% |
| 2024 | €21.43 Million | -23.08% |
| 2023 | €27.85 Million | -12.16% |
| 2022 | €31.71 Million | -28.49% |
| 2021 | €44.34 Million | -42.13% |
| 2020 | €76.62 Million | +1.60% |
| 2019 | €75.41 Million | +8.69% |
| 2018 | €69.38 Million | -36.11% |
| 2017 | €108.60 Million | +1.55% |
| 2016 | €106.94 Million | -4.83% |
| 2015 | €112.37 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of Bluelinea SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.00 Million USD |
| MoneyControl | $3.00 Million USD |
| MarketWatch | $3.00 Million USD |
| marketcap.company | $3.00 Million USD |
| Reuters | $3.00 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bluelinea SA
Bluelinea Société Anonyme provides health services for elderly and disabled people in France. It offers seniors and home services, including day and night family, and elder support related services. The company also provides connected establishments services that protects residents while assisting caregivers and staff in shared accommodation between seniors, serviced residences, EHPADs, specializ… Read more